Atrial Fibrillation Program

Patient-Centered, Multispecialty Approach to Managing Atrial Fibrillation

Atrial fibrillation (AFib) is the most common type of arrhythmia (abnormal heartbeat). Causes of atrial fibrillation can range from heart defects or abnormalities to unexplained causes, but those living with AFib are five times more likely to suffer a stroke. The goals of AFib treatment include regaining a normal heart rhythm and controlling the heart rate.

The Atrial Fibrillation Program within Tampa General Hospital’s Heart and Vascular Institute provides highly individualized care, recognizing that each patient’s situation is unique. Under the direction of expert electrophysiologists (a cardiologist who specializes in heart rhythm conditions), our model of care emphasizes working closely with you, your referring physician, and a team of atrial fibrillation specialists. Our multidisciplinary approach to care combined with high-volume experience allows us to develop a safe and effective treatment plan and to monitor your progress and response to treatment.

Transforming AFib Care Through Innovation

At Tampa General, we’re committed to staying at the forefront of AFib care through advanced technology, patient-centered tools, and groundbreaking research. We embrace the role of wearable technology in early detection and patient advocacy. Many patients arrive with data from smartwatches or fitness trackers that help identify previously undiagnosed AFib. We welcome this proactive approach and use wearable data to guide diagnosis and treatment planning.

As the region's only academic health system*, we’re actively involved in clinical trials and offer access to the latest therapies often not available at other hospitals. TGH is currently participating in the CONFORM trial, evaluating a next-generation left atrial appendage occlusion (LAAO) device, offering several innovative device options for patients who are not candidates for long-term blood thinners.

Our team is also at the forefront of treatment options, pioneering the use of pulsed field ablation (PFA) with three advanced platforms: Sphere-9, PulseSelect, and Farapulse. We also perform EtOH ablations for mitral flutter and we treat patients with advanced structural heart disease. In select cases, we offer concomitant procedures that combine AFib ablation with LAAO for comprehensive rhythm and stroke protection.

*University-Based Program

World-Class Care for Atrial Fibrillation

Our program is nationally recognized for the treatment of AFib and other cardiac arrhythmias, giving our patients access to the most advanced treatments. Patient education is a cornerstone of our care model, and we’ll make sure you understand your condition and treatment options. Each patient receives an individualized care plan, guided by a dedicated AFib Nurse Navigator who serves as a consistent point of contact throughout their journey. At TGH, you’ll have the information you need to make educated decisions about your immediate and long-term care. From diagnosis to treatment and follow-up, our team is here to support every step. 

Our goals at the Atrial Fibrillation Program are to:

• Increase awareness of, screening for, and diagnosing of AFib.
• Reduce the incidence of cardiac and cerebrovascular injury associated with AFib.
• Educate patients about their health and treatment options associated with AFib as a diagnosis.

Who should visit the Atrial Fibrillation Program?

A visit to our program is best for patients who:

• Have been newly diagnosed with AFib.
• Have been diagnosed with AFib but can improve their response to their current medications and treatments.
• Have high-risk for problems associated with AFib and require specialized treatment.
• Are seeking a second opinion.